Next Science Competitors, Revenue, Alternatives and Pricing

Claim your profile


Chatswood, NSW Australia
Total Funding:N/A
Lead Investor(s):N/A

Industry Ranking

Estimated Revenue & Financials

  • Next Science's estimated annual revenue is currently $9.3M per year.
  • Next Science's estimated revenue per employee is $155,000

Employee Data

  • Next Science has 60 Employees.
  • Next Science grew their employee count by 40% last year.
  • Next Science currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
Missing a competitor? Contribute!?

Next Science pioneers innovative, proprietary technologies to address the problem of biofilm. With proven, experienced management and scientific leadership, Next Science and its partners deliver break-through solutions that see beyond the current limits imposed by powerful bacterial colonies. Next Science offers a new solution to the biofilm problem with a proprietary, non-toxic technology that disrupts the biofilm's extracellular polymeric substance (EPS) matrix and, unlike competitors, offers no known opportunity for bacterial resistance. Recent clinical studies and field evaluations have shown Next Science products advance healing, reduce the number of bacteria present, and regardless of setting, help to prevent the growth of further biofilm structures. Next Science looks to partner with companies, organizations, and research institutions that share its future-forward vision of shifting the paradigm of biofilm eradication. In particular, Next Science looks to build effective collaborations with commercials partners who excel in a number of different therapeutic areas for licensing. Please contact us for a meeting.



Number of Employees


Revenue (est)


Current Jobs


Employee Growth %


Total Funding







Next Science News

09/03/2019 - Readers share favorite destinations for our next ‘science trip’

The “science trip” that we took Washington Post readers on this month featured a dozen sites with scientific importance, from the setting in ...

09/08/2019 - Antibiotic developer Next Science emerges on top

Biotechnology start-up Next Science (ASX: NXS) has emerged as one of the top five performing stocks on the ASX with investors recognising a ...

09/03/2019 - India’s Chandrayaan-2 mission loses contact with lunar lander

The next southernmost lander, China's Chang'e-4, sits at a southern latitude ... going to be another very good place for science and exploration.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing